138 related articles for article (PubMed ID: 11260418)
41. Optimizing waiting duration for renal transplants in the setting of renal malignancy: is 2 years too long to wait?
Nguyen KA; Syed JS; Luciano R; Shuch B; Vourganti S
Nephrol Dial Transplant; 2017 Oct; 32(10):1767-1773. PubMed ID: 28967967
[TBL] [Abstract][Full Text] [Related]
42. The role of pre-emptive re-transplant in graft and recipient outcome.
Goldfarb-Rumyantzev AS; Hurdle JF; Baird BC; Stoddard G; Wang Z; Scandling JD; Barenbaum LL; Cheung AK
Nephrol Dial Transplant; 2006 May; 21(5):1355-64. PubMed ID: 16476722
[TBL] [Abstract][Full Text] [Related]
43. [Access to the waiting list and renal transplantation].
Hourmant M; de Cornelissen F; Brunet P; Pavaday K; Assogba F; Couchoud C; Jacquelinet C;
Nephrol Ther; 2013 Sep; 9 Suppl 1():S139-66. PubMed ID: 24119579
[TBL] [Abstract][Full Text] [Related]
44. Kidney transplant outcomes in patients with Fabry disease.
Shah T; Gill J; Malhotra N; Takemoto SK; Bunnapradist S
Transplantation; 2009 Jan; 87(2):280-5. PubMed ID: 19155985
[TBL] [Abstract][Full Text] [Related]
45. Survival benefit of kidney and liver transplantation for obese patients on the waiting list.
Pelletier SJ; Maraschio MA; Schaubel DE; Dykstra DM; Punch JD; Wolfe RA; Port FK; Merion RM
Clin Transpl; 2003; ():77-88. PubMed ID: 15387099
[TBL] [Abstract][Full Text] [Related]
46. Heart transplantation 1985-1998: 13-years experience at Angelo De Gasperis Cardio-Thoracic Department-Milan.
Colombo T; Vitali E; Lanfranconi M; Russo C; Bruschi G; Marchetti C; Colucci V; Frigerio M; Oliva F; Grassi M; Gronda E; Merli M; Pellegrini A
Clin Transpl; 1998; ():315-25. PubMed ID: 10503110
[TBL] [Abstract][Full Text] [Related]
47. Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?
Gigante M; Neuzillet Y; Patard JJ; Tillou X; Thuret R; Branchereau J; Timsit MO; Terrier N; Boutin JM; Sallusto F; Karam G; Barrou B; Chevallier D; Mazzola CR; Delaporte V; Doeffler A; Kleinclauss F; Badet L; ;
BJU Int; 2012 Dec; 110(11 Pt B):E570-3. PubMed ID: 22726451
[TBL] [Abstract][Full Text] [Related]
48. Kidney transplantation in the older adult.
Knoll GA
Am J Kidney Dis; 2013 May; 61(5):790-7. PubMed ID: 23261121
[TBL] [Abstract][Full Text] [Related]
49. Outcomes in cardiac transplant recipients using allografts from older donors versus mortality on the transplant waiting list; Implications for donor selection criteria.
Lietz K; John R; Mancini DM; Edwards NM
J Am Coll Cardiol; 2004 May; 43(9):1553-61. PubMed ID: 15120811
[TBL] [Abstract][Full Text] [Related]
50. Association of antibody induction with short- and long-term cause-specific mortality in renal transplant recipients.
Meier-Kriesche HU; Arndorfer JA; Kaplan B
J Am Soc Nephrol; 2002 Mar; 13(3):769-772. PubMed ID: 11856783
[TBL] [Abstract][Full Text] [Related]
51. Infection and Malignancy Outweigh Cardiovascular Mortality in Kidney Transplant Recipients: Post Hoc Analysis of the FAVORIT Trial.
Weinrauch LA; D'Elia JA; Weir MR; Bunnapradist S; Finn PV; Liu J; Claggett B; Monaco AP
Am J Med; 2018 Feb; 131(2):165-172. PubMed ID: 28943384
[TBL] [Abstract][Full Text] [Related]
52. Quantification of the early risk of death in elderly kidney transplant recipients.
Gill JS; Schaeffner E; Chadban S; Dong J; Rose C; Johnston O; Gill J
Am J Transplant; 2013 Feb; 13(2):427-32. PubMed ID: 23167257
[TBL] [Abstract][Full Text] [Related]
53. Kidney transplantation halts cardiovascular disease progression in patients with end-stage renal disease.
Meier-Kriesche HU; Schold JD; Srinivas TR; Reed A; Kaplan B
Am J Transplant; 2004 Oct; 4(10):1662-8. PubMed ID: 15367222
[TBL] [Abstract][Full Text] [Related]
54. Increased immunosuppressive vulnerability in elderly renal transplant recipients.
Meier-Kriesche HU; Ojo A; Hanson J; Cibrik D; Lake K; Agodoa LY; Leichtman A; Kaplan B
Transplantation; 2000 Mar; 69(5):885-9. PubMed ID: 10755545
[No Abstract] [Full Text] [Related]
55. Is it time to increase access to transplantation for those with diabetic end-stage kidney disease?
Chadban SJ; Staplin ND
Kidney Int; 2014 Sep; 86(3):464-6. PubMed ID: 25168496
[TBL] [Abstract][Full Text] [Related]
56. Eligibility for the kidney transplant wait list: a model for conceptualizing patient risk.
Kiberd BA; Tennankore KK; West K
Transplant Res; 2014 Jan; 3(1):2. PubMed ID: 24401550
[TBL] [Abstract][Full Text] [Related]
57. Causes of death after renal transplantation.
Briggs JD
Nephrol Dial Transplant; 2001 Aug; 16(8):1545-9. PubMed ID: 11477152
[No Abstract] [Full Text] [Related]
58. Distance from treatment facility and risk of death from cardiovascular and infectious causes in renal transplant patients.
Soliman AR; Fathy A; Elkhatib M; Soliman MA; Shaheen N
Indian J Nephrol; 2013 Mar; 23(2):98-102. PubMed ID: 23716914
[TBL] [Abstract][Full Text] [Related]
59. Infectious Process Complicating Renal Transplantation.
Sparagana M; Rubnitz ME; Jonasson O; Vana M
Postgrad Med; 1974 Dec; 56(7):109-115. PubMed ID: 27409394
[No Abstract] [Full Text] [Related]
60. Is Cardiovascular-Renal Disease Increasing as a Cause of Death in Canada?
Macklin MT
Can Med Assoc J; 1936 Jan; 34(1):56-64. PubMed ID: 20320131
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
